Schizoaffective Disorder Clinical Trials in Boston, Massachusetts
4 studies are recruiting for schizoaffective disorder in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Cerebellar Modulation of Cognition in Psychosis
The goal of this clinical trial is to learn about cognition in psychotic disorders (schizophrenia, bipolar disorder, and schizoaffective disorder). The main question it aims to answer is: Can we use magnetic stimulation to change processing speed (how quickly people can solve challenging tasks). Pa…
- Stage
- Not phased
- Ages
- 18 to 55
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- Mclean Hospital
-
CLOZAPINE Response in Biotype-1
The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as ps…
- Stage
- Phase 4
- Ages
- 18 to 60
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Locations
- 5 in total
- Run by
- University of Texas Southwestern Medical Center
-
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia, Schizoaffective Disorder, and Bipolar I Disorder. It involves gathering mental health information, brain scans (MRI), eye movement …
- Stage
- Not phased
- Ages
- 18 to 40
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Locations
- 6 in total
- Run by
- Beth Israel Deaconess Medical Center
-
Enhanced Coordinated Specialty Care for Early Psychosis
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is: • Does the addition of certain elements of care increase the number of visits in treatm…
- Stage
- Not phased
- Ages
- Any age
- Site
- Massachusetts General Hospital FEPP Clinic, Boston, Massachusetts
- Locations
- 5 in total
- Run by
- Mclean Hospital
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.